4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen

C99H192N18O7Si — CID 159060990

IUPAC4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen
SMILESCC1(C)CC(OCCC[Si](C)(C)O)CC(C)(C)N1.COC1CC(C)(C)N(CCOC(=O)CCC(C)=O)C(C)(C)C1.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC2CCCCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.[H][H]
InChIInChI=1S/C35H66N8.C33H62N8O.C17H31NO4.C14H31NO2Si.H2/c1-26-36-30(38-27-18-14-13-15-19-27)39-31(37-26)43(29-24-34(6,7)41-35(8,9)25-29)21-17-12-11-16-20-42(10)28-22-32(2,3)40-33(4,5)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-13(19)7-8-15(20)22-10-9-18-16(2,3)11-14(21-6)12-17(18,4)5;1-13(2)10-12(11-14(3,4)15-13)17-8-7-9-18(5,6)16;/h27-29,40-41H,11-25H2,1-10H3,(H,36,37,38,39);26-27,37-38H,11-24H2,1-10H3;14H,7-12H2,1-6H3;12,15-16H,7-11H2,1-6H3;1H
InChIKeyJYLVEOHRUVJBAT-UHFFFAOYSA-N
MW1774.83 g/mol
LogP17.49
Rot. Bonds35

About 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen

4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen (PubChem CID 159060990) has the molecular formula C99H192N18O7Si and a molecular weight of 1774.83 g/mol. Its IUPAC name is 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen.

Molecular Properties

Compound Name4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen
PubChem CID159060990
Molecular FormulaC99H192N18O7Si
Molecular Weight1774.83 g/mol
Exact Mass1773.50
IUPAC Name4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen
SMILESCC1(C)CC(OCCC[Si](C)(C)O)CC(C)(C)N1.COC1CC(C)(C)N(CCOC(=O)CCC(C)=O)C(C)(C)C1.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC2CCCCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.[H][H]
InChIInChI=1S/C35H66N8.C33H62N8O.C17H31NO4.C14H31NO2Si.H2/c1-26-36-30(38-27-18-14-13-15-19-27)39-31(37-26)43(29-24-34(6,7)41-35(8,9)25-29)21-17-12-11-16-20-42(10)28-22-32(2,3)40-33(4,5)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-13(19)7-8-15(20)22-10-9-18-16(2,3)11-14(21-6)12-17(18,4)5;1-13(2)10-12(11-14(3,4)15-13)17-8-7-9-18(5,6)16;/h27-29,40-41H,11-25H2,1-10H3,(H,36,37,38,39);26-27,37-38H,11-24H2,1-10H3;14H,7-12H2,1-6H3;12,15-16H,7-11H2,1-6H3;1H
InChIKeyJYLVEOHRUVJBAT-UHFFFAOYSA-N
XLogP17.49
TPSA260.25 Ų
H-Bond Donors7
H-Bond Acceptors25
Rotatable Bonds35
Heavy Atoms125
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001774.83
LogP ≤ 517.49
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen?
The IUPAC name of 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen (CID 159060990) is 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen.
What is the SMILES notation for 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen?
The canonical SMILES for 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen is CC1(C)CC(OCCC[Si](C)(C)O)CC(C)(C)N1.COC1CC(C)(C)N(CCOC(=O)CCC(C)=O)C(C)(C)C1.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC2CCCCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.[H][H].
What is the InChIKey of 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen?
The InChIKey is JYLVEOHRUVJBAT-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H66N8.C33H62N8O.C17H31NO4.C14H31NO2Si.H2/c1-26-36-30(38-27-18-14-13-15-19-27)39-31(37-26)43(29-24-34(6,7)41-35(8,9)25-29)21-17-12-11-16-20-42(10)28-22-32(2,3)40-33(4,5)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-13(19)7-8-15(20)22-10-9-18-16(2,3)11-14(21-6)12-17(18,4)5;1-13(2)10-12(11-14(3,4)15-13)17-8-7-9-18(5,6)16;/h27-29,40-41H,11-25H2,1-10H3,(H,36,37,38,39);26-27,37-38H,11-24H2,1-10H3;14H,7-12H2,1-6H3;12,15-16H,7-11H2,1-6H3;1H.
What are the key properties of 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen?
4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen has a molecular weight of 1774.83 g/mol, XLogP of 17.49, 35 rotatable bonds, 7 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-cyclohexyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;hydroxy-dimethyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]silane;2-(4-methoxy-2,2,6,6-tetramethylpiperidin-1-yl)ethyl 4-oxopentanoate;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;molecular hydrogen is sourced from PubChem (CID 159060990), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).